Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E遗传性血管性水肿伴plasminogen基因K330E突变患者的 hypertension 风险The Journal of Allergy and Clinical Immunology: In PracticeIF02025-05-150PRE
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (vol 16, 86, 2021)ORPHANET JOURNAL OF RARE DISEASESIF3.52021-07-280OAAI
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyORPHANET JOURNAL OF RARE DISEASESIF3.52021-02-1523OAAI
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic ParametersTHROMBOSIS AND HAEMOSTASISIF4.32020-11-178OAAI
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidenceORPHANET JOURNAL OF RARE DISEASESIF3.52020-10-1567OAAI
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen geneORPHANET JOURNAL OF RARE DISEASESIF3.52020-02-1737OAAI
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findingsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62019-07-0111OAAI
Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United StatesORPHANET JOURNAL OF RARE DISEASESIF3.52018-10-1218OAAI
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62018-09-0169OAAI
Use Of Central Venous Access Devices (CVAD) And Associated Outcomes In Hereditary Angioedema (HAE) Patients: Findings From A Large United States (US) Claims DatabaseJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22018-02-010OAAI
Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary AngioedemaCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32018-01-0914OAAI
Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedemaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-06-012OAAI
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorNEW ENGLAND JOURNAL OF MEDICINEIF78.52017-03-23178OAAI
Intravenous C1-INH [C1-INH(IV)] Use Among Patients with Hereditary Angioedema (HAE) in the United States (US) and Associated Health Care Resource Utilization (HCRU)JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-02-010OAAI
Placebo-Controlled Trials of C1-Inhibitor (C1-INH) Replacement Therapy for Routine Prevention of Attacks in Patients with Hereditary Angioedema (HAE)JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-02-011OAAI
C1-Esterase Inhibitor Concentrate for Acute Laryngeal Hereditary Angioedema (HAE) Attacks: Different Treatment Response Based on Dosing Regimen?JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010OAAI
Safety of C1-Esterase Inhibitor in Acute and Prophylactic Therapy of Hereditary Angioedema: Findings from the Ongoing International Berinert Patient RegistryJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62015-03-0124PREAI
Clinical Usage of a C1 Esterase Inhibitor Concentrate for Hereditary Angioedema: Final Results from a Large International RegistryJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-010OAAI
The Effect of Weight on the Efficacy and Safety of C1 Esterase Inhibitor Concentrate for the Treatment of Acute Hereditary Angio edemaCLINICAL THERAPEUTICSIF3.62014-04-011PREAI
C1-Esterase Inhibitor Concentrate For Acute Attacks Of Laryngeal Edema In Hereditary Angioedema (HAE): Fixed Dosing Vs Body Weight-Adjusted DosingJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22014-02-010OA